Role of AlgC and GalU in the Intrinsic Antibiotic Resistance of Helicobacter pylori

References

• Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med. 2002;347(15):1175–1186. doi:10.1056/NEJMra020542
   PubMed Web of Science ®Google Scholar
• Naumann M, Crabtree JE. Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis. Trends Microbiol. 2004;12(1):29–36. doi:10.1016/j.tim.2003.11.005
   PubMed Web of Science ®Google Scholar
• Kocsmár É, Buzás GM, Szirtes I, et al. Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides. Nat Commun. 2021;12(1):2255. doi:10.1038/s41467-021-22557-7
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022. doi:10.1136/gutjnl-2022-327745
   Web of Science ®Google Scholar
• Liou JM, Lin JT, Chang CY, et al. Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design. Gut. 2010;59(5):572–578. doi:10.1136/gut.2009.198309
   PubMed Web of Science ®Google Scholar
• Nikaido H, Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev. 1985;49(1):1–32. doi:10.1128/mr.49.1.1-32.1985
   PubMedGoogle Scholar
• Berbís M, Sánchez-Puelles JM, Cañada FJ, Jiménez-Barbero J. Structure and Function of Prokaryotic UDP-Glucose Pyrophosphorylase, A Drug Target Candidate. Curr Med Chem. 2015;22(14):1687–1697. doi:10.2174/0929867322666150114151248
   PubMed Web of Science ®Google Scholar
• Paterson GK, Cone DB, Peters SE, Maskell DJ. The enzyme phosphoglucomutase (Pgm) is required by Salmonella enterica serovar Typhimurium for O-antigen production, resistance to antimicrobial peptides and in vivo fitness. Microbiology. 2009;155(Pt 10):3403–3410. doi:10.1099/mic.0.029553-0
   PubMedGoogle Scholar
• Felek S, Muszyński A, Carlson RW, Tsang TM, Hinnebusch BJ, Krukonis ES. Phosphoglucomutase of Yersinia pestis is required for autoaggregation and polymyxin B resistance. Infect Immun. 2010;78(3):1163–1175. doi:10.1128/iai.00997-09
   PubMed Web of Science ®Google Scholar
• McKay GA, Woods DE, MacDonald KL, Poole K. Role of phosphoglucomutase of Stenotrophomonas maltophilia in lipopolysaccharide biosynthesis, virulence, and antibiotic resistance. Infect Immun. 2003;71(6):3068–3075. doi:10.1128/iai.71.6.3068-3075.2003
   PubMed Web of Science ®Google Scholar
• Zou Y, Feng S, Xu C, et al. The role of galU and galE of Haemophilus parasuis SC096 in serum resistance and biofilm formation. Vet Microbiol. 2013;162(1):278–284. doi:10.1016/j.vetmic.2012.08.006
   PubMed Web of Science ®Google Scholar
• Jiang SS, Lin TY, Wang WB, Liu MC, Hsueh PR, Liaw SJ. Characterization of UDP-Glucose Dehydrogenase and UDP-Glucose Pyrophosphorylase Mutants of Proteus mirabilis: defectiveness in Polymyxin B Resistance, Swarming, and Virulence. Antimicrob Agents Chemother. 2010;54(5):2000–2009. doi:10.1128/aac.01384-09
   PubMed Web of Science ®Google Scholar
• Nesper J, Lauriano CM, Klose KE, Kapfhammer D, Kraiss A, Reidl J. Characterization of Vibrio cholerae O1 El tor galU and galE mutants: influence on lipopolysaccharide structure, colonization, and biofilm formation. Infect Immun. 2001;69(1):435–445. doi:10.1128/iai.69.1.435-445.2001
   PubMed Web of Science ®Google Scholar
• Liu AN, Teng KW, Chew Y, Wang PC, Nguyen TTH, Kao MC. The Effects of HP0044 and HP1275 Knockout Mutations on the Structure and Function of Lipopolysaccharide in Helicobacter pylori Strain 26695. Biomedicines. 2022;10:1. doi:10.3390/biomedicines10010145
   Web of Science ®Google Scholar
• Wen Y, Huang H, Tang T, et al. AI-2 represses CagA expression and bacterial adhesion, attenuating the Helicobacter pylori-induced inflammatory response of gastric epithelial cells. Helicobacter. 2021:e12778. doi:10.1111/hel.12778
   PubMed Web of Science ®Google Scholar
• Yang H, Huang X, Zhang X, et al. AI-2 Induces Urease Expression Through Downregulation of Orphan Response Regulator HP1021 in Helicobacter pylori. Front Med. 2022;9. doi:10.3389/fmed.2022.790994
   Web of Science ®Google Scholar
• Cammarota G, Martino A, Pirozzi G, et al. High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection. Aliment Pharmacol Ther. 2004;19(7):789–795. doi:10.1111/j.1365-2036.2004.01910.x
   PubMed Web of Science ®Google Scholar
• Li H, Yang T, Liao T, et al. The redefinition of Helicobacter pylori lipopolysaccharide O-antigen and core-oligosaccharide domains. PLoS Pathog. 2017;13(3):e1006280. doi:10.1371/journal.ppat.1006280
   PubMed Web of Science ®Google Scholar
• Järvinen N, Mäki M, Räbinä J, Roos C, Mattila P, Renkonen R. Cloning and expression of Helicobacter pylori GDP-l-fucose synthesizing enzymes (GMD and GMER) in Saccharomyces cerevisiae. Eur j Biochem. 2001;268(24):6458–6464. doi:10.1046/j.0014-2956.2001.02601.x
   PubMedGoogle Scholar
• Wu B, Zhang Y, Wang PG. Identification and characterization of GDP-d-mannose 4,6-dehydratase and GDP-l-fucose synthetase in a GDP-l-fucose biosynthetic gene cluster from Helicobacter pylori. Biochem Biophys Res Commun. 2001;285(2):364–371. doi:10.1006/bbrc.2001.5137
   PubMed Web of Science ®Google Scholar
• Kwon DH, Woo JS, Perng CL, Go MF, Graham DY, El-Zaatari FA. The effect of galE gene inactivation on lipopolysaccharide profile of Helicobacter pylori. Curr Microbiol. 1998;37(2):144–148. doi:10.1007/s002849900354
   PubMed Web of Science ®Google Scholar
• Li H, Liao T, Debowski AW, et al. Lipopolysaccharide Structure and Biosynthesis in Helicobacter pylori. Helicobacter. 2016;21(6):445–461. doi:10.1111/hel.12301
   PubMed Web of Science ®Google Scholar
• Bertani B, Ruiz N. Function and Biogenesis of Lipopolysaccharides. EcoSal Plus. 2018;8:1. doi:10.1128/ecosalplus.ESP-0001-2018
   Google Scholar
• Tang Y, Tang G, Pan L, Zhu H, Zhou S, Wei Z. Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China. Sci Rep. 2020;10(1):15403. doi:10.1038/s41598-020-72400-0
   PubMed Web of Science ®Google Scholar
• Cox G, Wright GD. Intrinsic antibiotic resistance: mechanisms, origins, challenges and solutions. Int J Med Microbiol. 2013;303(6–7):287–292. doi:10.1016/j.ijmm.2013.02.009
   PubMed Web of Science ®Google Scholar
• MacNair CR, Brown ED. Outer Membrane Disruption Overcomes Intrinsic, Acquired, and Spontaneous Antibiotic Resistance. mBio. 2020;11(5). doi:10.1128/mBio.01615-20
   PubMed Web of Science ®Google Scholar
• Coyne MJ, Russell KS, Coyle CL, Goldberg JB. The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core. J Bacteriol. 1994;176(12):3500–3507. doi:10.1128/jb.176.12.3500-3507.1994
   PubMed Web of Science ®Google Scholar
• Zhou D, Stephens D, Gibson B, et al. Lipooligosaccharide biosynthesis in pathogenic Neisseria. Cloning, identification, and characterization of the phosphoglucomutase gene. Proteins. 1994;269(15):11162–11169. doi:10.1016/S0021-9258(19)78105-8
   Google Scholar
• West NP, Jungnitz H, Fitter JT, McArthur JD, Guzmán CA, Walker MJ. Role of phosphoglucomutase of Bordetella bronchiseptica in lipopolysaccharide biosynthesis and virulence. Infect Immun. 2000;68(8):4673–4680. doi:10.1128/iai.68.8.4673-4680.2000
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/s1473-3099(17)30753-3
   PubMed Web of Science ®Google Scholar
• Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother. 1997;41(12):2621–2628. doi:10.1128/aac.41.12.2621
   PubMed Web of Science ®Google Scholar
• Khan R, Nahar S, Sultana J, Ahmad MM, Rahman M. T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. Antimicrob Agents Chemother. 2004;48(9):3567–3569. doi:10.1128/aac.48.9.3567-3569.2004
   PubMed Web of Science ®Google Scholar
• Edwards DI. Nitroimidazole drugs--action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother. 1993;31(1):9–20. doi:10.1093/jac/31.1.9
   PubMed Web of Science ®Google Scholar
• Jeong JY, Mukhopadhyay AK, Dailidiene D, et al. Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori. J Bacteriol. 2000;182(18):5082–5090. doi:10.1128/jb.182.18.5082-5090.2000
   PubMed Web of Science ®Google Scholar
• Luna E, Kim S, Gao Y, Widmalm G, Im W. Influences of Vibrio cholerae Lipid A Types on LPS Bilayer Properties. J Phys Chem B. 2021;125(8):2105–2112. doi:10.1021/acs.jpcb.0c09144
   PubMed Web of Science ®Google Scholar
• Vuorio R, Vaara M. The lipid A biosynthesis mutation lpxA2 of Escherichia coli results in drastic antibiotic supersusceptibility. Antimicrob Agents Chemother. 1992;36(4):826–829. doi:10.1128/aac.36.4.826
   PubMed Web of Science ®Google Scholar
• Lee CR, Lee JH, Jeong BC, Lee SH. Lipid a biosynthesis of multidrug-resistant pathogens - a novel drug target. Curr Pharm Des. 2013;19(36):6534–6550. doi:10.2174/13816128113199990494
   PubMed Web of Science ®Google Scholar
• Lin J, Zhang X, Wen Y, Chen H, She F, Newly Discovered A. Drug Resistance Gene rfaF In Helicobacter pylori. Infect Drug Resist. 2019;12:3507–3514. doi:10.2147/IDR.S231152
   PubMed Web of Science ®Google Scholar
• Stiers KM, Muenks AG, Beamer LJ. Biology, Mechanism, and Structure of Enzymes in the alpha-d-Phosphohexomutase Superfamily. Adv Protein Chem Struct Biol. 2017;109:265–304. doi:10.1016/bs.apcsb.2017.04.005
   PubMed Web of Science ®Google Scholar
• Qaria MA, Kumar N, Hussain A, et al. Roles of Cholesteryl-α-Glucoside Transferase and Cholesteryl Glucosides in Maintenance of Helicobacter pylori Morphology, Cell Wall Integrity, and Resistance to Antibiotics. mBio. 2018;9:6. doi:10.1128/mBio.01523-18
   Web of Science ®Google Scholar
• Kobayashi J, Kawakubo M, Fujii C, et al. Cholestenone functions as an antibiotic against Helicobacter pylori by inhibiting biosynthesis of the cell wall component CGL. Proc Natl Acad Sci U S A. 2021;118:16. doi:10.1073/pnas.2016469118
   Web of Science ®Google Scholar
• Mehra-Chaudhary R, Mick J, Tanner JJ, Henzl MT, Beamer LJ. Crystal structure of a bacterial phosphoglucomutase, an enzyme involved in the virulence of multiple human pathogens. Proteins. 2011;79(4):1215–1229. doi:10.1002/prot.22957
   PubMed Web of Science ®Google Scholar
• Lai X, Wu J, Chen S, Zhang X, Wang H. Expression, purification, and characterization of a functionally active Mycobacterium tuberculosis UDP-glucose pyrophosphorylase. Protein Expr Purif. 2008;61(1):50–56. doi:10.1016/j.pep.2008.05.015
   PubMed Web of Science ®Google Scholar